Advertisements

Rosiden Gel

Quick links to important sections

Rosiden Gel

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Rosiden Gel

Quick Facts

Property Description
Active Ingredient Piroxicam
Form Gel for external use
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Use Symptomatic relief of localized pain and inflammation
Origin Synthetic (Enolic acid derivative)

What Type of Medicine is Rosiden Gel?

Rosiden Gel is a medicinal product defined as a Nonsteroidal Anti-inflammatory Drug (NSAID), whose active substance, Piroxicam, belongs to the oxicam chemical class. The medicine is supplied in the pharmaceutical dosage form of a gel intended for topical application onto the skin. This defines the medicine's role in easing discomfort associated with inflammation.

The drug is a synthetic compound derived from the enolic acid derivative group. Unlike oral NSAID preparations, Rosiden Gel is specifically formulated for topical use, which is intended to provide localized therapeutic benefit while minimizing the systemic exposure associated with tablets or capsules. Its fundamental purpose is to manage both pain and inflammation through this focused, non-systemic approach.

Composition and General Purpose of Piroxicam Gel

The composition of Rosiden Gel is a single-ingredient product, containing the active entity Piroxicam (commonly at a 0.5% concentration) dispersed within a stabilizing gel base or vehicle. This base is typically an aqueous or hydroalcoholic formulation stabilized by gelling agents, which facilitates the controlled transdermal penetration of the active substance.

The general therapeutic purpose is rooted in Piroxicam's mechanism, which acts as a Cyclooxygenase (COX) Inhibitor to block the production of prostaglandins—the chemical messengers involved in causing inflammation and pain. By delivering anti-inflammatory and analgesic effects directly where the discomfort is perceived, Rosiden Gel offers a focused approach for the symptomatic relief of localized conditions, such as general musculoskeletal disorders and soft tissue disorders.

Advertisements

What side effects are possible with Rosiden Gel?

Possible Side Effects and Safety Information

The official safety profile for Rosiden Gel (Piroxicam Gel 0.5%), a topical nonsteroidal anti-inflammatory drug (NSAID), is primarily characterized by adverse reactions localized to the application site. These effects are classified according to standardized regulatory terminology (e.g., Common, Uncommon, Rare) provided by government health authorities.


Adverse Reaction Classifications

Side effects are primarily categorized under Skin and Subcutaneous Tissue Disorders. Common adverse reactions, which are the most frequently documented, include localized skin irritation, erythema (redness), pruritus (itching), rash, and forms of dermatitis. These localized effects are noted in regulatory documents as being most frequently observed during the initial weeks of treatment.

Classification Examples of Documented Effects
Common Localized skin irritation, erythema, pruritus, dermatitis.
Rare/Very Rare Systemic effects, Severe Cutaneous Adverse Reactions (SCARs).

Serious and Systemic Safety Potential

While systemic exposure is minimal, the official safety profile formally acknowledges the potential for rare, but serious, adverse reactions associated with the NSAID class. Very Rare documented systemic effects include Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), as well as systemic Angioedema. The potential for systemic effects is primarily associated with prolonged use of large quantities or application over extensive skin areas.


Safety Constraints and Considerations

Regulatory documents outline specific constraints related to application. The gel is contraindicated in individuals with known hypersensitivity to Piroxicam, aspirin, or other NSAIDs. Furthermore, the product must not be applied to damaged skin, open wounds, lesions, or mucous membranes. The official labeling also notes that photosensitivity reactions can occur and are linked to exposure to strong sunlight or UV-radiation during and shortly after use.

Advertisements

Overdose and Emergency Response

Although Rosiden Gel is applied topically, excessive use may lead to systemic exposure to its active ingredient, Piroxicam, resulting in documented overdose manifestations. These symptoms primarily affect the Gastrointestinal and Central Nervous Systems.

Officially Documented Manifestations

System Signs and Symptoms
GI / Sensory Nausea, vomiting, stomach pain, severe headache, ringing in the ears (tinnitus).
CNS Drowsiness, confusion, agitation, convulsions, decreased consciousness (coma).

When to Seek Immediate Medical Help

Overdose may result in severe or life-threatening outcomes, including potential for Gastrointestinal bleeding and acute renal failure. The most serious risks documented in official labeling include Cardiovascular Thrombotic Events, such as myocardial infarction (heart attack) and stroke, which can be fatal.

Regulatory guidance mandates that emergency medical care must be sought immediately for any suspected overdose. Contact the Poison Help line or call the local emergency number if the person has collapsed, is unresponsive, or exhibits symptoms of a stroke (e.g., slurred speech) or a heart attack (e.g., chest pain).

No specific antidote is known for Piroxicam. Management in a medical setting focuses on symptomatic and supportive treatment, which may involve the use of activated charcoal, airway support, and continuous monitoring of vital signs and the heart (ECG).

Advertisements

Therapeutic Uses of Rosiden Gel

What Rosiden Gel Treats: Main Uses and Benefits

This medicine is used in situations involving certain distressing symptoms, in line with guidance on topical non-steroidal treatments. The medicine is applied across domains where additional symptomatic support is needed, consistent with regulatory guidance on this class of treatment. Rosiden Gel helps address symptom clusters related to physical discomfort that may appear suddenly or intensify over time, such as those associated with conditions involving episodic tension, functional strain, and localized discomfort.

It is commonly used across conditions presenting with episodic or fluctuating manifestations, often during phases when symptoms become more noticeable. It offers symptomatic relief that may help patients cope more steadily with disruptive symptom manifestations. The application of the gel is relevant when symptoms cluster into patterns requiring supportive management. As one of the key benefits, the gel “provides support that may assist with easing the overall symptom load.”


Quick Fact

Quick Fact: Relevant for Localized Discomfort


This gel is generally considered relevant in conditions marked by periods of heightened symptoms, and it may contribute to improved day-to-day comfort during symptomatic periods.

Advertisements

Eligibility and Restrictions for Use

Rosiden Gel (Piroxicam Gel) is subject to specific regulatory eligibility criteria that determine who is permitted to use the medicine and who is formally prohibited.

Who Must Not Use Rosiden Gel (Contraindications)

Use is strictly prohibited for individuals with known hypersensitivity to the active ingredient, Piroxicam, or any component in the gel. It is also contraindicated for patients with a history where aspirin or other NSAIDs induced symptoms of asthma, urticaria, or angioedema. Furthermore, the gel is strictly contraindicated during the third trimester of pregnancy and must not be applied to skin areas that are broken, infected, or affected by dermatoses.

Populations Requiring Caution or Restriction

Specific populations are subject to conditional use. Use is officially not suitable or not established in children under 12 years of age. For elderly patients and individuals with pre-existing renal, hepatic, or cardiac impairment, regulatory documents advise caution. The gel is also not recommended for women who are breastfeeding, those in the first or second trimester of pregnancy, or women who are actively attempting to conceive.

Advertisements

What should I know about interactions with other medicines?

Rosiden Gel's interaction profile is documented primarily through its classification as a Nonsteroidal Anti-inflammatory Drug (NSAID) with the potential for low-level systemic exposure. This requires consideration of the known interaction rules for systemic piroxicam.

Pharmacodynamic Interactions

Co-administration with anticoagulants such as Warfarin is officially documented to increase the risk of bleeding. Similarly, concurrent use with anti-platelet agents or SSRIs/SNRIs raises the risk of serious gastrointestinal adverse events, including hemorrhage. When used alongside blood pressure medications like ACE Inhibitors or Angiotensin Receptor Blockers (ARBs), regulatory documents state the potential for a reduction in the antihypertensive effect.

Pharmacokinetic and Metabolic Constraints

Piroxicam's metabolism is influenced by the CYP2C9 isoenzyme. Regulatory documents state that individuals identified as CYP2C9 poor metabolizers may exhibit abnormally high piroxicam plasma concentrations, increasing the potential severity of all other systemic interactions. Oral antacids (aluminum or magnesium hydroxide) are officially documented to have no effect on the extent of systemic absorption.

Administration and Combination Restrictions

Combination with Aspirin or other NSAIDs is formally prohibited for individuals with a history of NSAID-induced asthma, urticaria, or allergic reactions. Furthermore, the official labeling imposes a restriction specific to the local application, stating that other topical medications must not be applied simultaneously to the same area of skin.

Advertisements

Mechanism of Action

Molecular Targeting of Cyclooxygenase Enzymes

The mechanism of Rosiden Gel is based on the action of Piroxicam, which acts exclusively at the site of application by modulating core physiological processes. The fundamental biochemical action is the reversible inhibition of the Cyclooxygenase ( COX) enzymes. Specifically, Piroxicam is a non-selective inhibitor of both the COX-1 and the inflammation-driven COX-2 isoforms, reversibly blocking the conversion of arachidonic acid into prostanoids.


Attenuation of Inflammatory and Nociceptive Pathways

The consequence of COX inhibition is the decrease in prostaglandin synthesis, particularly Prostaglandin E2 ( PGE2). By decreasing these mediators, the mechanism initiates a cascade that modulates local vascular responses, thereby affecting capillary vasodilation and increased permeability. Furthermore, lower PGE2 levels attenuate the sensitization of peripheral nociceptors (pain-sensing neurons), thus reducing the transmission of signals from the site of application.

Advertisements

Dosage and Administration Information

Administration Guidelines: Piroxicam 0.5% Gel

The use of Rosiden Gel follows specific procedures for this topical Nonsteroidal Anti-inflammatory Drug (NSAID). The medicine is designated solely for cutaneous use and is applied directly to the skin.

Dosing and Frequency

The standard adult dose is approximately 1 gram of gel per application. This quantity corresponds to a ribbon of gel measuring about 3 centimeters in length. This single dose is applied to the localized area of use. The typical frequency pattern is two to four times daily. Treatment duration is classified as short-term; the overall course of therapy is generally reviewed after 4 weeks of continuous use.

Procedural Constraints

Administration involves applying the dose and gently massaging it into the affected site until no residual material remains on the skin. A critical constraint in the use protocol is the instruction that occlusive dressings (such as tight bandages or wraps) must not be employed over the area where the gel has been applied. Additionally, users are required to wash their hands well after each application, unless the hands themselves are the area being treated.

Age-Specific Rules

Specific guidance exists for certain age groups. Older adults require no special precautions regarding dose adjustments for this topical form. Conversely, dosage recommendations and indications for use in the paediatric population (children under 15 years) have not been established.

Advertisements

Recent Clinical Evidence

Research has explored the evaluation of outcomes related to localized symptoms of mild to moderate osteoarthritis (OA), most commonly in the knee. The main body of evidence comes from short-term Randomized Controlled Trials (RCTs) and meta-analyses that consolidate findings from these trials. Studies monitored outcomes related to physical discomfort and daily functioning or activity level in adult out-patients. Findings describe patterns observed in these studies related to pain scores and functional outcomes over short-term observation periods.

Evidence also exists from short-term RCTs for conditions associated with acute or disruptive episodes, such as sprains and strains. These studies examined outcomes describing episodic or acute changes in pain and tenderness, often over periods of seven days or less. Data show patterns related to how frequently patients used additional pain medication when the gel was studied for localized pain following minor surgical procedures.

However, a common limitation is that follow-up durations were limited, typically to four weeks for chronic conditions, meaning the effect of continued observation over many months is not fully established. Research provides context but not individual predictions about the durability of response. Furthermore, data for certain groups remain insufficient, including for children or adolescents, and available evidence predominantly describes data from adult populations with localized conditions. The overall evidence quality varies across studies, and some subgroup findings are uncertain.

Key Studies & References

  1. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Rosiden Gel (FAQ)

Q: Is Rosiden Gel a steroid?

No, Rosiden Gel is not a steroid. The active ingredient, Piroxicam, is officially classified by health authorities as a Non-Steroidal Anti-inflammatory Drug (NSAID). This classification identifies its anti-inflammatory properties.


Q: What is Rosiden Gel officially approved to treat?

According to the official product information, Rosiden Gel is indicated for the topical management of pain and inflammation. This includes conditions such as osteoarthritis of superficial joints and acute musculoskeletal disorders. The medicine is also used for symptomatic relief in localized injuries like sprains.


Q: Are there different strengths of Rosiden Gel available?

Official product information most commonly specifies that the gel is available at a strength of 0.5% w/w (5 mg/g). The documentation for this specific product most commonly specifies the 0.5% strength.


Q: What is the consistency of Rosiden Gel like (is it thick or thin)?

Regulatory documents describe the pharmaceutical form as a gel intended for topical application to the skin. This substance is often visually specified as a clear, pale yellow gel.


Q: Can Rosiden Gel cause skin thinning or discoloration?

Official regulatory information documents changes to skin appearance, such as skin pigmentation, among the reported side effects of the gel.


Q: What kind of foods or drinks should be avoided while using Rosiden Gel?

Official drug documents generally do not contain any warnings or specific restrictions regarding food or drink that must be avoided while using the topical gel.


Q: What should be done if too much Rosiden Gel is applied?

Official documents advise that users consult with a doctor or pharmacist if an excessive amount of the gel is accidentally used or applied.


Q: Can Rosiden Gel affect blood test results?

While the gel has low systemic absorption, official labeling for the drug class notes that laboratory monitoring may be needed in some cases. This monitoring checks for potential systemic effects, specifically on renal (kidney) or hepatic (liver) function, in certain at-risk populations.


Q: Are there any documented cases of addiction or dependency related to Rosiden Gel?

According to official regulatory documents from various health authorities, the active substance, Piroxicam, is not associated with issues of dependence or abuse.


Q: Is Rosiden Gel available without a prescription in some places?

The legal status governing the supply of Rosiden Gel varies by country and region. In some areas, the 0.5% gel preparation requires a prescription, while in other areas, it may be available as a non-prescription, over-the-counter medicine.


Q: Is Rosiden Gel known to interact with herbal supplements?

Official documents advise informing a healthcare provider about all products, including herbal supplements, to assess for potential interactions before applying the gel.


Q: Does the time of day matter when applying Rosiden Gel?

Official dosing instructions primarily define the required frequency pattern for application, such as two to four times daily. However, the regulatory information does not specify a mandatory time of day when the gel must be applied.


Q: Are there different packaging sizes of Rosiden Gel available?

Regulatory documentation lists the specific pack sizes that are authorized for supply in a particular market. These authorized product listings can often include multiple tube sizes for the gel.


Q: What is the official definition of the condition that Rosiden Gel treats?

The official therapeutic indication describes the purpose of the medicine as the symptomatic relief of localized pain and inflammation. This includes conditions such as osteoarthritis (a disease of the joints) and various acute musculoskeletal injuries (such as sprains).


Q: Are there any specific warnings about driving or operating machinery while using Rosiden Gel?

Regulatory documents provide specific guidance that the use of Rosiden Gel is not expected to affect a person’s ability to drive or operate machinery.


Q: Is the active ingredient in Rosiden Gel found in any other types of medicine?

Yes, the active ingredient in Rosiden Gel, Piroxicam, is available in other dosage forms in addition to the gel. This includes oral forms like capsules or tablets, and sometimes suppositories, which are typically used to treat certain conditions systemically (throughout the body).


Q: Is it normal to feel a mild stinging or burning when first applying Rosiden Gel?

Official documents state that the gel contains ingredients, known as excipients, that may cause localized sensations. For instance, the alcohol component may cause a burning sensation on damaged skin. It is also described that the excipient propylene glycol may lead to mild skin irritation.


Q: Is there a list of ingredients in Rosiden Gel besides the main active component?

Yes, official documents provide information on the full composition of the gel. Besides the active ingredient, Piroxicam, there is a list of inactive ingredients, referred to as excipients. These are substances used in the gel base and may include components like propylene glycol, benzyl alcohol, and ethanol.


Q: Does Rosiden Gel interact with common over-the-counter pain relievers?

Official information indicates that use alongside other medications in the same drug class, such as aspirin or other NSAIDs, is prohibited for individuals with a history of certain allergic reactions. Patients are advised in official documentation to inform their healthcare provider about all medicines being taken, including over-the-counter pain relievers, to assess for potential interactions.


Q: Can Rosiden Gel be used on sensitive areas of the body?

According to regulatory instructions, this medicine must not be applied to mucous membranes (like the mouth or nostrils) or near the eyes. It is also strictly contraindicated for use on broken or damaged skin, including open wounds or lesions.


Q: How does the gel formulation affect how the medicine is absorbed?

The topical gel formulation is intended for use on the skin to provide localized effects where the product is applied. Official pharmacokinetic data indicates that the amount of the active ingredient that is absorbed into the general bloodstream (known as systemic exposure) is generally very low after topical application.


Q: Does Rosiden Gel contain any parabens or common preservatives?

The specific composition of the gel base, including any preservatives, is detailed in the official product information for its ingredients, or excipients. These excipients often include components such as propylene glycol, benzyl alcohol, and ethanol.


Q: Is there a risk of the active ingredient building up in the body over time?

Official product information states that the medicine is absorbed minimally into the bloodstream during proper topical use. However, regulatory documents note that the potential for systemic effects (effects throughout the body) may increase if the gel is used for a prolonged time, in large quantities, or over extensive skin areas.


Q: What have regulatory bodies said about the long-term safety of Rosiden Gel?

According to official regulatory documents, treatment with Rosiden Gel is classified as short-term use. Product instructions mandate that the overall course of therapy must be reviewed after 4 weeks of continuous use. This is because the clinical research evidence predominantly reflects outcomes observed over these shorter periods.


Q: Can Rosiden Gel be used by people who have diabetes or kidney issues?

Official product information advises that caution should be exercised when the gel is used by individuals with certain underlying health conditions. This includes individuals with certain conditions such as severe renal (kidney) impairment.


Q: Is it described in official sources that Rosiden Gel leaves a residue?

The official instructions for use advise the patient to apply the dose and then gently massage it into the affected area. This administration procedure is intended to continue until no residual material remains on the skin at the application site.

Advertisements

How should Rosiden Gel be stored and disposed of?

How to Store and Dispose of Rosiden Gel?

Rosiden Gel (Piroxicam 0.5% Gel) must be stored according to regulatory specifications to ensure product stability and safety.

Storage Requirements

The gel must be stored below 25 C and should be protected from light, freezing, and excessive heat. It is mandatory to keep the container tightly closed and store the gel in its original packaging. As a crucial safety measure, the medicine must be kept out of the sight and reach of children.

Stability and Disposal

Once the tube is first opened, the product should be used within 6 months. Unused or expired gel must be disposed of properly. The best method is through a community drug take-back program. If this is unavailable, the gel should be mixed with an undesirable substance, placed in a sealed bag, and discarded with household trash. The medicine must not be flushed down the toilet or poured down a drain.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Rosiden Gel found in:

A-Z Index: